Dr. Peter Rieckmann MD

Professor of Neurology and MS Research Chair, UNIVERSITY OF BRITISH COLUMBIA, THE


          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Member of the Healthcare Council

Request a consultation with Peter Rieckmann

Council Member Biography

Peter Rieckmann, MD, FRCPC, is Professor of Neurology and MS Research Chair at The University of British Columbia. He has established the Western Canadian MS Research and Training Center at UBC, Vancouver and is member of the EndMS steering committee (Canadian MS society). He has served as Vice President of the German Multiple Sclerosis Society and Coordinator of the Multiple Sclerosis Therapy Consensus Group. Dr. Rieckmann also holds positions on the European Committee for Trials and Research in Multiple Sclerosis (ECTRIMS), the medical advisory board of the Multiple Sclerosis International Federation, and the steering committees and advisory boards of various international multiple sclerosis trials. He has expertise in the pathophysiology and treatment of neuroimmunological disorders, multiple sclerosis, and molecular and functional aspects of blood-brain barrier disturbances. Dr. Rieckmann has published over 180 original articles in peer reviewed journals. (This is me - Update Profile)


Employment History

2007 - Unspecified
Professor of Neurology and MS Research Chair, UNIVERSITY OF BRITISH COLUMBIA, THE
2001 - 2009
Professor of Neurology and Research Group Leader, JULIUS- MAXIMILIANS UNIVERSITAT WURZBURG

GLG NewsSM Analyses by Peter Rieckmann

Opinions and analyses expressed in G+ Insights are solely those of the author. See the Terms of Use for details.


GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Peter Rieckmann has not published any GLG News Analyses.

GLG Study Groups with Peter Rieckmann(?)

Study Group Name No. Members
Neurologists 1903
Copaxone Prescribers for Multiple Sclerosis 126
Tysabri Prescribers for Multiple Sclerosis: Neurologists 87

GLG Live Meetings with Peter Rieckmann(?)

Peter Rieckmann has not participated in any GLG Live Meetings.

View all GLG Live Meetings in Healthcare